Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data-Reference-Cited by-同舟云学术

Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data

Published:2020-05 Issue:5 Volume:203 Page:949-956
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Fankhauser Christian D.¹,Grogg Josias B.¹,Hayoz Stefanie²,Wettstein Marian S.¹,Dieckmann Klaus-Peter³,Sulser Tullio¹,Bode Peter-Karl⁴,Clarke Noel W.⁵,Beyer Joerg⁶,Hermanns Thomas¹

Affiliation:

1. Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

2. SAKK Coordinating Center, Bern, Switzerland

3. Asklepios Klinik Altona, Hamburg, Germany

4. Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

5. The Christie and Salford Royal NHS Foundation Trusts, Manchester, United Kingdom

6. Department of Oncology, Inselspital Bern, University of Bern, Bern, Switzerland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions;Surgical and Experimental Pathology;2024-08-20

2. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium;European Journal of Cancer;2024-05

3. β‐Catenin alterations in testicular Leydig cell tumour: a immunohistochemical and molecular analysis;Histopathology;2024-03-26

4. Tumores no germinales del testículo;EMC - Urología;2024-03

5. Testis Cancer – Pathobiology of Different Tumor Types;Reference Module in Biomedical Sciences;2024